目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Oral drugs - Market size and forecast 2021-2026
Exhibit 28: Chart on Oral drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Oral drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Oral drugs - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Oral drugs - Year-over-year growth 2021-2026 (%)
5.4 Topical drugs - Market size and forecast 2021-2026
Exhibit 32: Chart on Topical drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Topical drugs - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Topical drugs - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Topical drugs - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Product
Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 Market opportunity By Geographical Landscape
Exhibit 62: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 63: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 64: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 65: Overview on factors of disruption
9.4 Industry risks
Exhibit 66: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 67: Vendors covered
10.2 Market positioning of vendors
Exhibit 68: Matrix on vendor position and classification
10.3 Aurobindo Pharma Ltd.
Exhibit 69: Aurobindo Pharma Ltd. - Overview
Exhibit 70: Aurobindo Pharma Ltd. - Product / Service
Exhibit 71: Aurobindo Pharma Ltd. - Key offerings
10.4 Bayer AG
Exhibit 72: Bayer AG - Overview
Exhibit 73: Bayer AG - Business segments
Exhibit 74: Bayer AG - Key news
Exhibit 75: Bayer AG - Key offerings
Exhibit 76: Bayer AG - Segment focus
10.5 Cipla Ltd.
Exhibit 77: Cipla Ltd. - Overview
Exhibit 78: Cipla Ltd. - Business segments
Exhibit 79: Cipla Ltd. - Key news
Exhibit 80: Cipla Ltd. - Key offerings
Exhibit 81: Cipla Ltd. - Segment focus
10.6 Eli Lilly and Co.
Exhibit 82: Eli Lilly and Co. - Overview
Exhibit 83: Eli Lilly and Co. - Business segments
Exhibit 84: Eli Lilly and Co. - Key offerings
Exhibit 85: Eli Lilly and Co. - Segment focus
10.7 Endo International Plc
Exhibit 86: Endo International Plc - Overview
Exhibit 87: Endo International Plc - Business segments
Exhibit 88: Endo International Plc - Key news
Exhibit 89: Endo International Plc - Key offerings
Exhibit 90: Endo International Plc - Segment focus
10.8 Futura Medical plc
Exhibit 91: Futura Medical plc - Overview
Exhibit 92: Futura Medical plc - Business segments
Exhibit 93: Futura Medical plc - Key offerings
Exhibit 94: Futura Medical plc - Segment focus
10.9 GlaxoSmithKline Plc
Exhibit 95: GlaxoSmithKline Plc - Overview
Exhibit 96: GlaxoSmithKline Plc - Business segments
Exhibit 97: GlaxoSmithKline Plc - Key news
Exhibit 98: GlaxoSmithKline Plc - Key offerings
Exhibit 99: GlaxoSmithKline Plc - Segment focus
10.10 Pfizer Inc.
Exhibit 100: Pfizer Inc. - Overview
Exhibit 101: Pfizer Inc. - Business segments
Exhibit 102: Pfizer Inc. - Key news
Exhibit 103: Pfizer Inc. - Key offerings
Exhibit 104: Pfizer Inc. - Segment focus
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 105: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 106: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 107: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 108: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 109: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 VIVUS Inc.
Exhibit 110: VIVUS Inc. - Overview
Exhibit 111: VIVUS Inc. - Business segments
Exhibit 112: VIVUS Inc. - Key news
Exhibit 113: VIVUS Inc. - Key offerings
Exhibit 114: VIVUS Inc. - Segment focus

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 115: Inclusions checklist
Exhibit 116: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 117: Currency conversion rates for US$
11.4 Research methodology
Exhibit 118: Research methodology
Exhibit 119: Validation techniques employed for market sizing
Exhibit 120: Information sources
11.5 List of abbreviations
Exhibit 121: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Oral drugs - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oral drugs - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oral drugs - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oral drugs - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Topical drugs - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Topical drugs - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Topical drugs - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Topical drugs - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Market opportunity By Geographical Landscape ($ million)
Exhibits63: Impact of drivers and challenges in 2021 and 2026
Exhibits64: Overview on Criticality of inputs and Factors of differentiation
Exhibits65: Overview on factors of disruption
Exhibits66: Impact of key risks on business
Exhibits67: Vendors covered
Exhibits68: Matrix on vendor position and classification
Exhibits69: Aurobindo Pharma Ltd. - Overview
Exhibits70: Aurobindo Pharma Ltd. - Product / Service
Exhibits71: Aurobindo Pharma Ltd. - Key offerings
Exhibits72: Bayer AG - Overview
Exhibits73: Bayer AG - Business segments
Exhibits74: Bayer AG - Key news
Exhibits75: Bayer AG - Key offerings
Exhibits76: Bayer AG - Segment focus
Exhibits77: Cipla Ltd. - Overview
Exhibits78: Cipla Ltd. - Business segments
Exhibits79: Cipla Ltd. - Key news
Exhibits80: Cipla Ltd. - Key offerings
Exhibits81: Cipla Ltd. - Segment focus
Exhibits82: Eli Lilly and Co. - Overview
Exhibits83: Eli Lilly and Co. - Business segments
Exhibits84: Eli Lilly and Co. - Key offerings
Exhibits85: Eli Lilly and Co. - Segment focus
Exhibits86: Endo International Plc - Overview
Exhibits87: Endo International Plc - Business segments
Exhibits88: Endo International Plc - Key news
Exhibits89: Endo International Plc - Key offerings
Exhibits90: Endo International Plc - Segment focus
Exhibits91: Futura Medical plc - Overview
Exhibits92: Futura Medical plc - Business segments
Exhibits93: Futura Medical plc - Key offerings
Exhibits94: Futura Medical plc - Segment focus
Exhibits95: GlaxoSmithKline Plc - Overview
Exhibits96: GlaxoSmithKline Plc - Business segments
Exhibits97: GlaxoSmithKline Plc - Key news
Exhibits98: GlaxoSmithKline Plc - Key offerings
Exhibits99: GlaxoSmithKline Plc - Segment focus
Exhibits100: Pfizer Inc. - Overview
Exhibits101: Pfizer Inc. - Business segments
Exhibits102: Pfizer Inc. - Key news
Exhibits103: Pfizer Inc. - Key offerings
Exhibits104: Pfizer Inc. - Segment focus
Exhibits105: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits106: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits107: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits108: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits109: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits110: VIVUS Inc. - Overview
Exhibits111: VIVUS Inc. - Business segments
Exhibits112: VIVUS Inc. - Key news
Exhibits113: VIVUS Inc. - Key offerings
Exhibits114: VIVUS Inc. - Segment focus
Exhibits115: Inclusions checklist
Exhibits116: Exclusions checklist
Exhibits117: Currency conversion rates for US$
Exhibits118: Research methodology
Exhibits119: Validation techniques employed for market sizing
Exhibits120: Information sources
Exhibits121: List of abbreviations